BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 23110550)

  • 1. Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.
    Martowicz A; Spizzo G; Gastl G; Untergasser G
    BMC Cancer; 2012 Oct; 12():501. PubMed ID: 23110550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth.
    Martowicz A; Rainer J; Lelong J; Spizzo G; Gastl G; Untergasser G
    Mol Cancer; 2013 Jun; 12():56. PubMed ID: 23758908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.
    Osta WA; Chen Y; Mikhitarian K; Mitas M; Salem M; Hannun YA; Cole DJ; Gillanders WE
    Cancer Res; 2004 Aug; 64(16):5818-24. PubMed ID: 15313925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion.
    Sankpal NV; Mayfield JD; Willman MW; Fleming TP; Gillanders WE
    Breast Cancer Res; 2011; 13(6):R124. PubMed ID: 22132731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient but not stable ZEB1 knockdown dramatically inhibits growth of malignant pleural mesothelioma cells.
    Horio M; Sato M; Takeyama Y; Elshazley M; Yamashita R; Hase T; Yoshida K; Usami N; Yokoi K; Sekido Y; Kondo M; Toyokuni S; Gazdar AF; Minna JD; Hasegawa Y
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3(Suppl 3):S634-45. PubMed ID: 22086445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of EpCAM overexpression on human breast cancer cell lines.
    Gostner JM; Fong D; Wrulich OA; Lehne F; Zitt M; Hermann M; Krobitsch S; Martowicz A; Gastl G; Spizzo G
    BMC Cancer; 2011 Jan; 11():45. PubMed ID: 21281469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasis.
    Gao J; Liu X; Yang F; Liu T; Yan Q; Yang X
    Oncotarget; 2015 Sep; 6(29):27187-98. PubMed ID: 26356670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy.
    Yanamoto S; Kawasaki G; Yoshitomi I; Iwamoto T; Hirata K; Mizuno A
    Oral Oncol; 2007 Oct; 43(9):869-77. PubMed ID: 17207659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer.
    Zhou N; Wang H; Liu H; Xue H; Lin F; Meng X; Liang A; Zhao Z; Liu Y; Qian H
    J Exp Clin Cancer Res; 2015 Dec; 34():157. PubMed ID: 26698569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EpCAM, a potential therapeutic target for esophageal squamous cell carcinoma.
    Matsuda T; Takeuchi H; Matsuda S; Hiraiwa K; Miyasho T; Okamoto M; Kawasako K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S356-64. PubMed ID: 24566863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer.
    Driemel C; Kremling H; Schumacher S; Will D; Wolters J; Lindenlauf N; Mack B; Baldus SA; Hoya V; Pietsch JM; Panagiotidou P; Raba K; Vay C; Vallböhmer D; Harréus U; Knoefel WT; Stoecklein NH; Gires O
    Oncogene; 2014 Oct; 33(41):4904-15. PubMed ID: 24141784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by AP1-dependent EpCAM expression in MCF-7 cells.
    Gao J; Yan Q; Wang J; Liu S; Yang X
    J Cell Physiol; 2015 Apr; 230(4):775-82. PubMed ID: 25205054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EpCAM modulates NF-κB signaling and interleukin-8 expression in breast cancer.
    Sankpal NV; Fleming TP; Gillanders WE
    Mol Cancer Res; 2013 Apr; 11(4):418-26. PubMed ID: 23378578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1.
    Bao B; Azmi AS; Aboukameel A; Ahmad A; Bolling-Fischer A; Sethi S; Ali S; Li Y; Kong D; Banerjee S; Back J; Sarkar FH
    J Biol Chem; 2014 May; 289(21):14520-33. PubMed ID: 24719318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer.
    Subramanian N; Kanwar JR; Kanwar RK; Sreemanthula J; Biswas J; Khetan V; Krishnakumar S
    PLoS One; 2015; 10(7):e0132407. PubMed ID: 26176230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
    Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cervical carcinoma cell lines overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody.
    Richter CE; Cocco E; Bellone S; Bellone M; Casagrande F; Todeschini P; Rüttinger D; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Int J Gynecol Cancer; 2010 Dec; 20(9):1440-7. PubMed ID: 21370592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.
    Amoury M; Kolberg K; Pham AT; Hristodorov D; Mladenov R; Di Fiore S; Helfrich W; Kiessling F; Fischer R; Pardo A; Thepen T; Hussain AF; Nachreiner T; Barth S
    Cancer Lett; 2016 Mar; 372(2):201-9. PubMed ID: 26806809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncoupling of the ERα regulated morphological phenotype from the cancer stem cell phenotype in human breast cancer cell lines.
    Gadalla SE; Alexandraki A; Lindström MS; Nistér M; Ericsson C
    Biochem Biophys Res Commun; 2011 Feb; 405(4):581-7. PubMed ID: 21266162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.